Microcirculatory dysfunction in sepsis: A pathogenetic basis for therapy?

Journal of Pathology

Volumn 190, Issue 3, 2000, Pages 373-386

  Lehr, Hans Anton ^a   Bittinger, Fernando ^a   Kirkpatrick, C James ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Animal models; Endothelium; In vitro models; Microcirculatory dysfunction; Sepsis; Therapy

Indexed keywords

HEAT SHOCK PROTEIN; NITRIC OXIDE;

BLOOD CLOTTING; ENDOTHELIUM CELL; MICROCIRCULATION; NEUTROPHIL; NONHUMAN; OXYGEN CONSUMPTION; OXYGEN TRANSPORT; PATHOGENESIS; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SEPSIS; SIGNAL TRANSDUCTION;

ANIMALS; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; ENDOTOXINS; HUMANS; INFLAMMATION MEDIATORS; MICROCIRCULATION; NEUTROPHILS; SEPSIS;

EID: 0034008116     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(200002)190:3<373::AID-PATH593>3.0.CO;2-3     Document Type: Review

References (162)

1. Fry DE, Pearlstein L, Fulton RL, Polk HC. Multiple system organ failure. The role of uncontrolled infection. Arch Surg 1980; 115: 136-140.
2. Bell RC, Coalson JJ, Smith JD, Johanson WG. Multiple organ system failure and infection in adult respiratory distress syndrome. Ann Intern Med 1983; 99: 293-298.
3. Beal AL, Cerra FB. Multiple organ failure syndrome in the 1990s. Systemic inflammatory response and organ dysfunction. J Am Med Assoc 1994; 271: 226-233.
4. Lehr HA, Arfors KE. Mechanisms of tissue damage by leukocytes. Curr Opin Haematol 1994; 1: 92-99.
5. Astiz ME, DeGent GE, Lin RY, Rackow EC. Microvascular function and rheologic changes in hyperdynamic sepsis. Crit Care Med 1995; 23: 265-271.
6. Chernow B, Roth BL. Pharmacologic manipulation of the peripheral vasculature in shock: clinical and experimental approaches. Circ Shock 1986; 18: 141-155.
7. Hollenberg SM, Cunnion RE. Endothelial and vascular smooth muscle function in sepsis. J Crit Care 1994; 9: 262-280.
8. Friedlander MH, Simon R, Machiedo GW. The relationship of packed cell transfusion to red blood cell deformability in systemic inflammatory response syndrome patients. Shock 1998; 9: 84-88.
9. Linderkamp O, Ruef P, Brenner B, Gulbins E, Lang F. Passive deformability of mature, immature, and active neutrophils in healthy and septicemic neonates. Pediatr Res 1998; 44: 946-950.
10. Todd JC III, Mollitt DL. Sepsis-induced alterations in the erythrocyte membrane. Am Surg 1994; 60: 954-957.
11. Knisley MH, Cowley RA, Hawthorne I, Garris D. Separation of shock types. Experimental and clinical separation of hypovolemic and septic shock. Angiology 1970; 21: 728-744.
12. Diaz NL, Finol HJ, Torres SH, Zambrano CI, Adjounian H. Histochemical and ultrastructural study of skeletal muscle in patients with sepsis and multiple organ failure syndrome (MOFS). Histol Histopathol 1998; 13: 121-128.
13. Christ F, Gamble J, Gartside IB, Kox WJ. Increased microvascular water permeability in patients with septic shock, assessed with venous congestion plethysmography (VCP). Intensive Care Med 1998; 24: 18-27.
14. McGill SN, Ahmed NA, Christou NV. Increased plasma von Willebrand factor in the systemic inflammatory response syndrome is derived from generalized endothelial cell activation. Crit Care Med 1998; 26: 296-300.
15. Kirkpatrick CJ, Bittinger F, Klein CL, Hauptmann S, Klosterhalfen B. The role of the microcirculation in multiple organ dysfunction syndrome (MODS): a review and perspective. Virchows Arch 1996; 427: 461-476.
16. Duranteau J, Sitbon P, Teboul JL, et al. Effects of epinephrine, norepinephrine or the combination of norepinephrine and dobutamine on gastric mucosa in septic shock. Crit Care Med 1999; 27: 893-900.
17. Bakker J, Coffernils M, Leon M, Gris P, Vincent JL. Blood lactate levels are superior to oxygen-derived variables in predicting outcome in human septic shock. Chest 1991; 99: 956-962.
18. Tuchschmidt J, Oblitas D, Fried JC. Oxygen consumption in sepsis and septic shock. Crit Care Med 1991; 19: 664-671.
19. Marik P. Gastric intramucosal pH. A better predictor of multiorgan dysfunction syndrome and death than oxygen-derived variables in patients with sepsis. Chest 1993; 104: 225-229.
20. Astiz ME, Rackow EC, Falk JL, Kaufman BS, Weil MH. Oxygen delivery and consumption in patients with hyperdynamic septic shock. Crit Care Med 1987; 15: 26-28.
21. Kaufman B, Rackow EC, Falk JL. The relationship between oxygen delivery and consumption during fluid resuscitation of hypovolemic and septic shock. Chest 1984; 85: 336-340.
22. Danek SJ, Lynch JP, Weg JG, Dantzker DR. The dependence of oxygen uptake on oxygen delivery in the adult respiratory distress syndrome. Am Rev Respir Dis 1980; 122: 387-395.
23. 2 consumption in the adult respiratory distress syndrome. Chest 1983; 84: 267-271.
24. Ronco JJ, Fenwick JC. Wiggs BR, Phang PT, Russel JA. Tweeddale G. Oxygen consumption is independent of increases in oxygen delivery by dobutamine in septic patients who have normal or increased plasma lactate. Am Rev Respir Dis 1993; 147: 25-31.
25. Tyml K, Yu J, McCormack DG. Capillary and arteriolar responses to local vasodilators are impaired in a rat model of sepsis. J Appl Physiol 1998; 84: 837-844.
26. Cameron EM, Wang SY, Fink MP, Sellke FW. Mesenteric and skeletal muscle microvascular responsiveness in subacute sepsis. Shock 1998; 9: 184-192.
27. 2+ mobilization and nitric oxide biosynthesis in cultured endothelial cells. Circ Res 1994; 75: 659-668.
28. Li H, Förstermann U. Nitric oxide in the pathogenesis of vascular disease. J Pathol 2000; 190: 244-254.
29. Schneider F, Bucher B, Schott C, Andre A, Julou-Schaeffer G, Stoclet JC. Effect of bacterial lipopolysaccharide on function of rat small femoral arteries. Am J Physiol 1994; 266: H191-H198.
30. Hollenbcrg SM, Piotrowski MJ, Parrillo JE. Nitric oxide synthase inhibition reverses arteriolar hyporesponsiveness to endothelin-1 in rats. Am J Physiol 1997; 272: R969-R974.
31. Hollenberg SM, Tangora JJ, Piotrowski MJ, Easington C, Parrillo JE. Impaired microvascular vasoconstrictive responses to vasopressin in septic rats. Crit Care Med 1997; 25: 869-873.
32. Sair M, Etherington PJ, Curzen NP, Winlove CP, Evans TW. Tissue oxygenation and perfusion in endotoxemia. Am J Physiol 1996; 271: 1620-1625.
33. Tucker JJ, Wilson MA, Wead WB, Garrison RN. Microvascular endothelial cell control of peripheral vascular resistance during sepsis. Arch Surg 1998; 133: 1335-1342.
34. Ince C, Sinaasappel M. Microcirculatory oxygenation and shunting in sepsis and shock. Crit Care Med 1999; 27: 1369-1377.
35. Archie JP. Anastomotic arterial-venous shunting in endotoxic and septic shock in dogs. Ann Surg 1977; 186: 171-176.
36. Cronenwett JL, Lindenauer MS. Direct measurement of arteriovenous anastomotic blood flow in the septic canine hindlimb. Surgery 1979; 85: 275-282.
37. Hermreck AS, Thal AP. Mechanisms for high circulatory requirements in sepsis and septic shock. Ann Surg 1969; 170: 679-695.
38. Whitworth PW, Cryer HM, Garrison RN, Baumgarten TE, Harris PD. Hypoperfusion of the intestinal microcirculation without decreased cardiac output during live Escherichia coli sepsis in rats. Circ Shock 1989; 27: 111-122.
39. Madorin WS, Martin CM, Sibbald WJ. Dopexamine attenuates flow motion in ileal mucosal arterioles in normotensive sepsis. Crit Care Med 1999; 27: 394-400.
40. Farquhar I, Martin CM, Lam C, Potter R. Ellis CG, Sibbald WJ. Decreased capillary density in vivo in bowel mucosa of rats with normotensive sepsis. J Surg Res 1996; 61: 190-196.
41. Naziri W, Joshua IG. Role of tumor necrosis factor-alpha in small intestinal microcirculation. Am Surg 1998; 64: 203-209.
42. Hurd TC, Dasmahapatra KS, Ruch BF, Machiedo GW. Red blood cell deformability in human and experimental sepsis. Arch Surg 1988; 123: 217-220.
43. Wang P, Ba ZF, Tait SM, Zhou M, Chaudry IH. Alterations in circulating blood volume during polymicrobial sepsis. Circ Shock 1993; 40: 92-98.
44. Unger LS, Cryer HM, Garrison RN. Differential response of the microvasculature in the liver during bacteremia. Circ Shock 1989; 29: 335-344.
45. Lam C, Tyml K, Martin C, Sibbald W. Microvascular perfusion is impaired in a rat model of normotensive sepsis. J Clin Invest 1994; 94: 2077-2083.
46. Hinshaw LB, Archer LT, Beller-Todd BK, Benjamin B, Flournoy DJ, Passey R. Survival of primates in lethal septic shock following delayed treatment with steroid. Circ Shock 1981; 8: 291-300.
47. Rackow EC, Astiz ME. Pathophysiology and treatment of septic shock. J Am Med Assoc 1991; 266: 548-554.
48. Barroso-Aranda J, Zweifach BW, Mathison JC, Schmidt-Schönbein GW. Neutrophil activation, tumor necrosis factor, and survival after endotoxic and hemorrhagic shock. J Cardiovasc Pharmacol 1995; 25: 23-29.
49. Lehr HA, Guhlmann A, Nolte D, Keppler D, Meßmer K. Leukotrienes as mediators in postischemic leukocyte/endothelium interaction in a microcirculation model in the hamster. J Clin Invest 1991; 87: 2036-2041.
50. Lentsch AB, Ward PA. Regulation of inflammatory vascular damage. J Pathol 2000; 190: 343-348
51. Carlos TM, Harlan JM. Leukocyte endothelial adhesion molecules. Blood 1994; 84: 2068-2101.
52. Liu SF, Ye X, Malik AB. Pyrrolidine dithiocarbamate prevents I-kappaB degradation and reduces microvascular injury induced by lipopolysaccharide in multiple organs. Mol Pharmacol 1999; 55: 658-667.
53. Jacschke H, Farhood A, Smith C. Neutrophil induced liver cell injury in endotoxin shock is a CD11b/CD18 dependent mechanism. Am J Physiol 1991; 261: G1051-G1056.
54. Eichacker PQ, Farese A, Hoffman W, et al. Leukocyte CD11b/ CD18 antigen-directed monoclonal antibody improves early survival and decreases hypoxemia in dogs challenged with tumor necrosis factor. Am Rev Respir Dis 1992; 145: 1023-1029.
55. Andersen BO, Bensard DD, Harken AH. The role of platelet activating factor and its antagonists in shock, sepsis and multiple organ failure. Surg Gynaecol Obstet 1991; 172: 415-424.
56. Schmidt W, Stenzel K, Gebhard MM, Martin E, Schmidt H. Cl-esterase inhibitor and its effects on endotoxin-induced leukocyte adherence and plasma extravasation in postcapillary venules. Surgery 1999; 125: 280-287.
57. Eichhorn M, Ney L, Suchner U, Goetz AE. Impact of arachidonic acid on microhemodynamics and leukocyte adhesion in alveolar capillaries during endotoxemia. Langenbecks Arch Chir I 1999; 115: 493-497.
58. Chien S, Chang C, Dellenback RJ, Usami S, Gregersen MI. Hemodynamic changes in endotoxin shock. Am J Physiol 1966; 210: 1401-1410.
59. Solomon LA, Hinshaw LB. Effects of endotoxin on isogravimetric capillary pressure in the forelimb. Am J Physiol 1968; 214: 443-447.
60. Blum MS, Toninelli E, Anderson JM, et al. Cytoskeletal rearrangement mediates human microvascular endothelial tight junction modulation by cytokines. Am J Physiol 1997; 273: H286-H294.
61. Voss BL, Dc Bault LE, Blick KE, et al. Sequential renal alterations in septic shock in the primate. Circ Shock 1991; 33: 142-155.
62. Rafi AQ, Zeytun A, Bradley MJ, et al. Evidence for the involvement of Fas ligand and perforin in the induction of vascular leak syndrome. J Immunol 1998; 161: 3077-3086.
63. Carden DL, Granger DN. Pathophysiology of ischaemia reperfusion injury. J Pathol 2000; 190: 255-266.
64. Klosterhalfen B, Hörstmann-Jungemann K, Vogel P, et al. Hemodynamic variables and plasma levels of PGI2, TXA2 and IL-6 in a porcine model of recurrent endotoxemia. Circ Shock 1991; 35: 237-244.
65. Hauptmann S. Klosterhalfen B, Weis J, Mittermayer C, Kirkpatrick CJ. Skeletal muscle oedema and muscle fibre necrosis during septic shock. Observations with a porcine septic shock model. Virchows Arch 1994; 424: 653-659.
66. Walsh CJ, Carey PD, Cook DJ, Bechard DE, Fowler AA, Sugerman HJ. Anti-CD 18 antibody attenuates neutropenia and alveolar capillary-membrane injury during Gram-negative sepsis. Surgery 1991; 110: 205-211.
67. Booke M, Hinder F, McGuire R, Traber LD, Traber DL. Selective inhibition of inducible nitric oxide synthase: effects on hemodynamics and regional blood flow in healthy and septic sheep. Crit Care Med 1999; 27: 162-167.
68. Szabo A, Salzman AL, Szabo C. Poly(ADP-ribose) synthetase activation mediates pulmonary microvascular and intestinal mucosal dysfunction in endotoxin shock. Life Sci 1998; 23: 2133-2139.
69. Neviere RR, Pitt-Hyde ML, Piper RD, Sibbald WJ, Potter RF. Microvascular perfusion deficits are not a prerequisite for mucosal injury in septic rats. Am J Physiol 1999; 276: 933-940.
70. Bevilacqua MP, Pober JS, Wheeler ME, Cotran RS, Gimbrone MA Jr. Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines. J Clin Invest 1985; 76: 2003-2011.
71. Bevilacqua MP, Pober JS, Mendrick DL, Cotran RS, Gimbrone MA Jr. Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci U S A 1987; 84: 9238-9242.
72. Cines DB, Pollak ES, Buck CA, et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998; 91: 3527-3561.
73. Krishnaswamy G, Kelley J, Yerra L, Smith JK, Chi DS. Human endothelium as a source of multifunctional cytokines: molecular regulation and possible role in human disease. J Interferon Cytokine Res 1999; 19: 91-104.
74. Kirkpatrick CJ, Wagner M, Hermanns I, et al. Physiology and cell biology of the endothelium: a dynamic interface for cell communication. Int J Microcirc 1997; 17: 231-240.
75. Billiau A, Van de Kerckhove F. Cytokines and their interactions with other inflammatory mediators in the pathogenesis of sepsis and septic shock. Eur J Clin Invest 1991; 21: 559-573.
76. Mueller AM, Cronen C, Mueller K-M, Kirkpatrick CJ. Comparative analysis of the reactivity of human umbilical vein endothelial cells in organ and monolayer culture. Pathohiology 1999; 67: 99-107.
77. Grau GE, Mili N, Lou JN, et al. Phenotypic and functional analysis of pulmonary microvascular endothelial cells from patients with acute respiratory distress syndrome. Lab Invest 1996; 74: 761-770.
78. Grau GE, de Moerloose P, Bulla O, et al. Haemostatic properties of human pulmonary and cerebral microvascular endothelial cells. Thromb Haemost 1997; 77: 585-590.
79. Marshall JC, Nathens AB. The gut in critical illness: evidence from human studies. Shock 1996; 6: S10-S16.
80. Fruchterman TM, Spain DA, Wilson MA, Harris PD, Garrison RN. Selective microvascular endothelial cell dysfunction in the small intestine following resuscitated hemorrhagic shock. Shock 1998; 10: 417-422.
81. Nilsen EM, Johansen FE, Jahnsen FL, et al. Cytokine profiles of cultured microvascular endothelial cells from the human intestine. Gut 1998; 42: 635-642.
82. Glauser MP, Zanetti G, Baumgartner JD, Cohen J. Septic shock: pathogenesis. Lancet 1991; 338: 732-736.
83. Patrick D, Betts J, Frey EA, Prameya R, Dorovini-Zis K, Finlay BB. Haemophilus influenzae lipopolysaccharide disrupts confluent monolayers of bovine brain endothelial cells via a serum-dependent cytotoxic pathway. J Infect Dis 1992; 165: 865-872.
84. Bannerman DD, Goldblum SE. Direct effects of endotoxin on the endothelium: barrier function and injury. Lab Invest 1999; 79: 1181-1199.
85. Dahinden C, Calanos C, Fehr J. Granulocyte activation by endotoxin. I. Correlation between adherence and other granulocyte functions, and role of endotoxin structure on biologic activity. J Immunol 1983; 130: 857-862.
86. Guthrie LA, McPhail C, Henson PM, Johnston RB. Priming of neutrophils for enhanced release of oxygen metabolites by bacterial lipopolysaccharide. Evidence for increased activity of the superoxide-producing enzyme. J Exp Med 1984; 160: 1656-1657.
87. Rosser DM, Manji M, Cooksley H, Bellingan G. Endotoxin reduces maximal oxygen consumption in hepatocytes independent of any hypoxic insult. Intensive Care Med 1998; 24: 725-729.
88. Hu X, Yee E, Harlan JM, Wong F, Karsan A. Lipopolysaccharide induces the antiapoptotic molecules, A1 and A20, in microvascular endothelial cells. Blood 1998; 92: 2759-2765.
89. Keel M, Hentze H, Künstle G, Trentz O, Ertel W. Endotoxin and interferon-γ inhibit the caspase-activity in neutrophils through a tyrosine kinase dependent mechanism. Langenbecks Arch Chir I 1999; 115: 515-517.
90. Bittinger F, Brochhausen C, Koehler H, et al. Differential expression of cell adhesion molecules in inflamed appendix: correlation with clinical stage. J Pathol 1998; 186: 422-428.
91. Steinhoff G, Behrend M, Schrader B, Duijvestijn AM, Wonigeit K. Expression patterns of leucocyte adhesion ligand molecules on human liver endothelia, lack of ELAM-1 and CD62 inducibility on sinusoidal endothelia and distinct distribution of VCAM-1, ICAM-1, ICAM-2 and LFA-3. Am J Pathol 1993; 142: 481-488.
92. Mueller AM, Cronen C, Kupferwasser LI, Oelert H, Mueller K-M, Kirkpatrick CJ. Expression of endothelial cell adhesion molecules on heart valves: upregulation in degeneration as well as acute endocarditis. J Pathol (in press).
93. Wagner M, Klein CL, van Kooten TG, Kirkpatrick CJ. Mechanisms of cell activation by heavy metal ions. J Biomed Mater Res 1998; 42: 443-452.
94. Tamura DY, Moore EE, Johnson JL, Zallen G, Aiboshi J, Silliman CC. p38 mitogen-activated protein kinase inhibition attenuates intercellular adhesion molecule-1 up-regulation on human pulmonary microvascular endothelial cells. Surgery 1998; 124: 403-407.
95. Lindquist S, Craig EA. The heat shock proteins. Annu Rev Genet 1988; 22: 631-677.
96. Welch WJ. Mammalian stress response: cell physiology, structure/function of stress proteins, and implications for medicine and disease. Physiol Rev 1992; 72: 1063-1081.
97. Jaattela M. Heat shock proteins as cellular lifeguards. Ann Med 1999; 31: 261-271.
98. Piotrowicz RS, Martin JL, Dillman WH, Levin EG. The 27-kDa heat shock protein facilitates basic fibroblast growth factor release from endothelial cells. J Biol Chem 1997; 272: 7042-7047.
99. Galdiero M, de I'Ero GC, Marcatili A. Cytokine and adhesion molecule expression in human monocytes and endothelial cells stimulated with bacterial heat shock proteins. Infect Immun 1997; 65: 699-707.
100. Wagner M, Hermanns I, Bittinger F, Kirkpatrick CJ. Induction of stress proteins in macro- and microvascular human endothelial cell types by heavy metal ions and heat shock. Am J Physiol Lung Cell Mol Physiol 1999; 277: L1026-L1033.
101. Zund G, Dzus AL, Pretre R, Niederhauser U, Vogt P, Turina M. Endothelial cell injury in cardiac surgery: salicylate may be protective by reducing expression of endothelial adhesion molecules. Eur J Cardiothorac Surg 1998; 13: 293-297.
102. Dore-Duffy P, Balabanov R, Beaumont T. Hritz MA, Harik SI, LaManna JC. Endothelial activation following prolonged hypobaric hypoxia. Microvasc Res 1999; 57: 75-85.
103. Faller DV. Endothelial cell responses to hypoxic stress. Clin Exp Pharmacol Physiol 1999; 26: 74-84.
104. Van SF, Tritto I, Pinsky D, et al. Induction of interleukin 6 (IL-6) in vascular cells. Central role of the binding site for nuclear factor-IL-6. J Biol Chem 1995; 270: 11463-11471.
105. Caplan MS, Adler L, Kelly A, Hsueh W. Hypoxia increases stimulus-induced PAF production and release from human umbilical vein endothelial cells. Biochim Biophys Acta 1992; 1128: 205-210.
106. Ogawa S, Shreeniwas R, Brett J, Clauss M, Furie M, Stern DM. The effect of hypoxia on capillary endothelial cell function: modulation of barrier and coagulant function. Br J Haematol 1990; 75: 517-524.
107. Klein CL, Koehler H, Bittinger F, Otto M, Hermanns I, Kirkpatrick CJ. Comparative studies on vascular endothelium in vitro. II. Hypoxia: its influences on endothelial cell proliferation and expression of cell adhesion molecules. Pathobiology 1995; 63: 1-8.
108. Graven KK, Farber HW. Endothelial cell hypoxic stress proteins. J Lab Clin Med 1998; 132: 456-463.
109. Ichikawa H, Flores S, Kvietys PR, et al. Molecular mechanisms of anoxia/reoxygenation-induced ncutrophil adherence to cultured endothelial cells. Circ Res 1997; 81: 922-931.
110. Howard EF, Chen Q, Cheng C, Carroll JE, Hess D. NF-kappa B is activated and ICAM-1 gene expression is upregulated during reoxygenation of human brain endothelial cells. Neurosci Lett 1998; 248: 199-203.
111. Bone C. The pathogenesis of sepsis. Ann Intern Med 1991; 115: 457-469.
112. Dries DJ. Activation of the clotting system and complement after trauma. New Horizons 1996; 4: 276-288.
113. Gullo A, Berlot G. Ingredients of organ dysfunction or failure. World J Surg 1996; 20: 430-436.
114. Baue AE, Durham R, Faist E. Systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), multiple organ failure (MOF): are we winning the battle? Shock 1998; 10: 79-89.
115. Cross A. Novel approaches to the treatment of sepsis: lessons learned and future directions. Shock 1996; 6: S71-S74.
116. Mulligan MS, Warner RL, Foreback JL, Shanley TP, Ward PA. Protective effects of IL-4, IL-10, IL-12, and IL-13 in IgG immune complex-induced lung injury: role of endogenous IL-12. J Immunol 1997; 159: 3483-3489.
117. Manna SK, Aggarwal BB. Interleukin-4 down-regulates both forms of tumor necrosis factor receptor and receptor-mediated apoptosis, NF-kappaB, AP-1, and c-jun N-terminal kinase. Comparison with interleukin-13. J Biol Chem 1998; 273: 3333-3341.
118. Ward PA, Lentsch AB. The acute inflammatory response and its regulation. Arch Surg 1999; 134: 666-669.
119. Bone RC. Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med 1996; 24: 1125-1128.
120. Moore FA, Haenel JB, Moore EE, Whitehall TA. Incommensurate oxygen consumption in response to maximal oxygen availability predicts postinjury multiple organ failure. J Trauma 1992; 33: 58-65.
121. Maynard ND, Bihari DJ, Dalton RN, Smithies MN, Mason RC. Increasing splanchnic blood flow in the critically ill. Chest 1995; 108: 1648-1654.
122. Cerra FB, Hassett J, Siegel JH. Vasodilator therapy in clinical sepsis with low output syndrome. J Surg Res 1978; 25: 180-183.
123. Vallance P, Moncada S. The role of endogenous nitric oxide in septic shock. New Horizons 1993; 1: 77-86.
124. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acatl Sci U S A 1991; 88: 4651-4655.
125. Harbrecht BG, Billiar TR, Stadler J, et al. Inhibition of nitric oxide synthesis during endotoxemia promotes intrahepatic thrombosis and an oxygen radical-mediated hepatic injury. J Leukoc Biol 1992; 52: 390-394.
126. Laszlo F, Whittle BJR, Evans SM, Moncada S. Association of microvascular leakage with induction of nitric oxide synthase: effects of nitric oxide synthase inhibitors in various organs. Eur J Pharmacol 1995; 283: 47-53.
127. Cobb JP, Natanson C, Hoffman WD, et al. N omega-amino-D-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin. J Exp Med 1992; 176: 1175-1182.
128. Petros A, Lamb G, Leone A, Moncada S, Bennett D, Vallence P. Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res 1994; 28: 34-39.
129. Kreimeier U, Frey L, Dentz J, Herbel T, Messmer K. Hypertonic saline dextran resuscitation during the initial phase of acute endotoxemia: effect on regional blood flow. Crit Care Med 1991; 19: 801-809.
130. Lehr HA, Saetzler RK, Thiel M, Arfors KE. Microvascular salvage by small volume resuscitation with hypertonic fluids concepts and facts. Prog Appl Microcirc 1996; 22: 167-180.
131. Luypaert P, Vincent JL, Domb M, et al. Fluid resuscitation with hypertonic saline in endotoxic shock. Circ Shock 1986; 20: 311-320.
132. Kristensen J, Modig J. Ringer's acetate and dextran-70 with or without hypertonic saline in endotoxin-induced shock in pigs. Crit Care Med 1990; 18: 1261-1268.
133. Horton JW, Walker PB. Small-volume hypertonic saline dextran resuscitation from canine endotoxemic shock. Ann Surg 1991; 214: 64-73.
134. Weeren FR, Tobias TA, Schertel ER, Allen DA, Brourman JD. Comparative effects of 7% NaCl in 6% dextran 70 and 0.9% NaCI on oxygen transport in endotoxemic dogs. Shock 1994; 1: 159-165.
135. Maciel F, Mook M, Zhang H, Vincent JL. Comparison of hypertonic with isotonic saline hydroxyethyl starch solution on oxygen extraction capabilities during endotoxic shock. Shock 1998; 9: 33-39.
136. Mullins RJ, Hudgens RW. Hypertonic saline resuscitates dogs in endotoxin shock. J Surf Res 1987; 453: 37-44.
137. Stelzer H, Owen AN, Krafft P, Weinstabl C, Hammerle AF. Haemodynamic evaluation during small volume resuscitation in patients with acute respiratory failure. Eur J Emerg Med 1994; 1: 19-26.
138. Rola-Pleszczynski M, Lemaire I. Leukotrienes augment interleukin-1 production by human monocytes. J Immunol 1985; 135: 3958-3961.
139. Young JS, Passmore JC. Hemodynamic and renal advantages of dual cyclooxygenase and leukotrienc blockade during canine endotoxic shock. Circ Shock 1990; 32: 243-255.
140. Cohn SM, Kruithoff KL, Rothschild HR, Wang HL, Antonsson JB, Fink MP. Beneficial effects of LY203647, a novel leukotriene C4/D4 antagonist, on pulmonary function and mesenteric perfusion in a porcine model of endotoxic shock and ARDS. Circ Shock 1991; 33: 7-16.
141. Badr KF, Kelley VE, Rennke HG, Brenner BM. Roles for thromboxane A2 and leukotrienes in endotoxin-induced acute renal failure. Kidney Int 1986; 30: 474-480.
142. Baudry N, Rasetti C, Vicaut E. Differences between cytokine effects in the microcirculation of the rat. Am J Physiol 1996; 271: 1186-1192.
143. Biliar TR, Bankey PE, Svingen BA, et al. Fatty acid intake and Kupffer cell function: fish oil alters eicosanoid and monokine production to endotoxin stimulation. Surgery 1988; 104: 343-349.
144. Krausz MM, Utsunomiya T, Feuerstein G, Wolfe JH, Shepro D. Hechtman HB. Prostacyclin reversal of lethal endotoxemia in dogs. J Clin Invest 1981; 67: 1118-1125.
145. Demling RH, Smith M, Gunther R, Gee M, Flynn J. The effect of prostacyclin infusion on endotoxin-induced lung injury. Surgery 1981; 89: 257-263.
146. Holcroft JW, Vassary MJ, Weber CJ. Prostaglandin E1 and survival in patients with the adult respiratory distress syndrome: a prospective trial. Ann Surg 1986; 203: 371-378.
147. Chang SW, Fedderson CO, Henson PM, Voelkel NF. Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats. J Clin Invest 1987; 79: 1498-1509.
148. Whittle BJR, Boughton-Smith NK, Hutcheson IR, Esplugues JV, Wallance JL. Increased intestinal formation of PAF in endotoxin-induced damage in the rat. Br J Pharmacol. 1987; 92: 3-4.
149. Klabunde RE, Calvello C. Inhibition of endotoxin-induced microvascular leakage by a platelet-activating factor antagonist and 5-lipoxygenase inhibitor. Shock 1995; 4: 368-372.
150. Chang SW, Fernyak S, Voelkel NF. Beneficial effect of a platelet-activating factor antagonist, WEB 2086, on endotoxin-induced lung injury. Am J Physiol 1990; 258: H153-H158.
151. Casals-Stenzel J. Protective effects of WEB 2086, a novel antagonist of platelet activating factor, in endotoxin shock. Eur J Pharmacol 1987; 135: 117-122.
152. Heuer H, Casals-Stenzel J. The pathophysiological role of PAF in anaphylactic lung reaction in the guinea pig and in endotoxin shock evidenced by the specific PAF-antagonist WEB 2086. Prog Clin Biol Res 1989; 308: 925-30.
153. Dhainaut JF, Tenaillon A, Le Tulzo Y, et al. Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: a randomized, double-blind, placebo-controlled, multicenter clinical trial. Crit Care Med 1994; 22: 1720-1728.
154. Krysztopik RJ, Bentley FR, Spain DA, Wilson MA, Garrison RN. Free radical scavenging by lazaroids improves renal blood flow during sepsis. Surgery 1996; 120: 657-662.
155. Krysztopik RJ, Bentley FR, Spain DA, Wilson MA, Garrison RN. Lazaroid improves intestinal blood flow in the rat during hyperdynamic bacteraemia. Surgery 1997; 84: 1717-1721.
156. Nonaka A, Manabe T, Tobe T. Effect of a new synthetic free radical scavenger, 2-octadecyl ascorbic acid, on the mortality in mouse endotoxemia. Life Sci 1990; 47: 1933-1939.
157. Steeb GD, Wilson MA, Garrison RN. Pentoxifylline preserves small intestine microvascular blood flow during bacteremia. Surgery 1992; 112: 756-763.
158. Nolte D, Kinner B, Schütze E, Leiderer R, Galanos C, Meßmer K. Effects of adenosine on intravascular accumulation of leukocytes and tissue damage in striated muscle during endotoxaemia. Langenbecks Arch Chir I 1998; 115: 173-175.
159. Hoffmann JN, Vollmar B, Inthorn D, Schildberg FW, Menger MD. Inhibition of endotoxin-induced leukocyte/endothelial cell interaction by antithrombin III - an intravital microscopic study in the skinfold chamber preparation in the hamster. Langenbecks Arch Surg 1999; Suppl 1: 503-506.
160. Hardaway RM. Traumatic and septic shock alias post-trauma critical illness. Br J Surg 1998; 85: 1473-1479.
161. Baeuerle P, Henkel T. Function and activation of NF-κB in the immune system. Annu Rev Immunol 1994; 12: 141-179.
162. Christman JW, Lancaster LH, Blackwell TS. Nuclear factor kappa B: a pivotal role in the systemic inflammatory response syndrome and new target for therapy. Intensive Care Med 1998; 24: 1131-1138.